CD Diagnostics
Research & development company
Tuesday, January 18, 2011
Embassy Suites, Chesterbrook, Pennsylvania (directions)
|
About
|
CD Diagnostics is developing a diagnostic test that uses biomarkers in synovial fluid to indicate the presence of
infection in total joint replacements. This diagnostic test focuses on the body's biological response to infection
rather than the infection itself. A major advantage of this test is that the test is specific and local to the joint
replacement. By measuring the presence of protein biomarkers in the synovial (joint) fluid around the total joint
replacement, this diagnostic test eliminates the potential for false positive or negative results that can occur with
general tests that use existing technology. CD Diagnostics conducted three studies that verify the accuracy and
specificity of this technology. The diagnostic test being developed by CD Diagnostics will be more accurate, take
less time, save money and establish a clearer picture for a patient's treatment pathway than existing technology.
3 Major Issues
|
-
CD Diagnostics has a solid technology with a strong patent that might increase in scope with a patent continuance that looks promising. Is it a better idea for CD Diagnostics to put all of it's energy into developing one product and selling the company, with it's technology, to a potential buyer or would it be better to develop an extended line of applications for this technology and then approach a potential buyer/partner?
-
CD Diagnostics has been approached by a couple of large companies that might be interested in a strategic partnership. Is a strategic partnership a good idea at this point for CD Diagnostics? What models for a strategic partnership would make sense?
-
CD Diagnostics is looking at models for pricing of Cygnasure®. What models exist to determine an appropriate price for a product like Cygnasure®? How should we begin to determine a price for Cygnasure®.
Program:
|
6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)
8:00 -, will deliver the Company's "Elevator" Pitch to the Group
8:20 - A Panel will address 3 Major Issues for the Company
9:00 - Open discussion: members and guests
<Top of the page>
|
 |
|
Slides
Audio
Video
Webcast
